AVTR
Avantor, Inc.
NYSE · Healthcare · Medical - Instruments & Supplies · US
$16.68
−0.06%Next report
Analyst consensus
- Next report date
- Feb 10, 2027
- EPS estimate
- $0.23
- Revenue estimate
- $1.7B
Latest reported
- Last report date
- Oct 28, 2026
- EPS actual
- $0.22
- EPS estimate
- $0.21
- Revenue actual
- $1.7B
- Revenue estimate
- $1.6B
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 9
- EPS misses (12Q)
- 2
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- +6.2%
- Revenue beats (12Q)
- 7
Analyst ratings
Sell-side consensus
- Consensus
- Hold
- Price target
- $17
- PT range
- $15 – $18
- Analysts
- 7
1 Buy5 Hold1 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Oct 28, 2026 | $0.21 | $0.22 | Beat 5.77% | $1.7B |
| Jul 29, 2026 | $0.19 | $0.21 | Beat 9.37% | $1.7B |
| Apr 29, 2026 | $0.16 | $0.17 | Beat 5.59% | $1.6B |
| Feb 11, 2026 | $0.21 | $0.22 | Beat 4.27% | $1.7B |
| Oct 29, 2025 | $0.23 | $0.22 | Miss -2.65% | $1.6B |
| Aug 1, 2025 | $0.25 | $0.24 | Miss -4.00% | $1.7B |
| Apr 25, 2025 | $0.23 | $0.23 | Miss -0.43% | $1.6B |
| Feb 7, 2025 | $0.25 | $0.27 | Beat 8.43% | $1.7B |
| Oct 25, 2024 | $0.25 | $0.26 | Beat 2.77% | $1.7B |
| Jul 26, 2024 | $0.23 | $0.25 | Beat 7.76% | $1.7B |
| Apr 26, 2024 | $0.20 | $0.22 | Beat 9.45% | $1.7B |
| Feb 14, 2024 | $0.22 | $0.25 | Beat 13.12% | $1.7B |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Feb 10, 2027